GLP-1 drugs are now a fixture of American health culture: 1 in 8 U.S. adults is taking a medication like Ozempic or Wegovy, and the ... Read more The post Did GLP-1 drugs kill keto? The new dietary ...

About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll released on Tuesday found ...

If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 ...

Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...

A 12-year-old walking into a pediatrician’s office today can walk out with a prescription for the same class ...

A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

UPS said the investment will speed up deliveries while improving tracking and oversight throughout the supply chain.

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the ...

A form of fibre that boosts the release of the hunger-reducing hormone GLP-1 has been approved as safe by a European ...

GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.